Zobrazeno 1 - 3
of 3
pro vyhledávání: '"T. I. Lobanova"'
Autor:
E. V. Usikova, K. D. Kaplanov, V. I. Vorob'ev, T. I. Lobanova, M. A. Ul'yanova, D. G. Kisilichina, Yu. N. Kobzev, D. I. Shikhbabaeva, O. Yu. Vinogradova, V. V. Ptushkin
Publikováno v:
Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, Vol 12, Iss 6, Pp 64-77 (2023)
Relevance and goals. Treatment of patients with acute myeloid leukemia has traditionally been highly intensive and includes induction therapy using cytarabine and anathracyclines. In addition to new opportunities in the treatment of acute myeloid leu
Externí odkaz:
https://doaj.org/article/0b6810be75d24a37be9a671bc5da96a4
Publikováno v:
Онкогематология, Vol 13, Iss 1, Pp 83-102 (2018)
Patients with acute myeloid leukemia (AML) have a high risk of relapse. Determination of the presence of residual tumor cells during the remission of AML allows predicting the onset of relapse. Slow decrease of blast cells after induction courses is
Externí odkaz:
https://doaj.org/article/a03ddf954a9944d795f05b4d50143cc4
Autor:
E. V. Usikova, K. D. Kaplanov, V. I. Vorob'ev, T. I. Lobanova, M. A. Ul'yanova, D. G. Kisilichina, Yu. N. Kobzev, D. I. Shikhbabaeva, O. Yu. Vinogradova, V. V. Ptushkin
Publikováno v:
Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH). 12:64-77
Relevance and goals. Treatment of patients with acute myeloid leukemia has traditionally been highly intensive and includes induction therapy using cytarabine and anathracyclines. In addition to new opportunities in the treatment of acute myeloid leu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62dd43a459e423a2066f90600fd9d1ce
https://doi.org/10.20340/vmi-rvz.2022.6.clin.5
https://doi.org/10.20340/vmi-rvz.2022.6.clin.5